Doximity Inc ( DOCS ) reported financial results for the fourth quarter of fiscal-year 2024 Thursday after the bell. Here’s a look at the key highlights from the quarter.

Q4 Earnings: Doximity’s fourth-quarter revenue increased 6% year-over-year to $118.1 million, which beat the consensus estimate of $116.4 million, according to Benzinga Pro. The company reported adjusted earnings of 25 cents per share, beating analyst estimates of 20 cents per share.

Doximity ( DOCS ) generated operating cash flow of $63.9 million, up 37% year-over-year. Free cash flow was also up 37% year-over-year to $62.3 million.

“We were pleased to beat on our top and bottom lines, as we delivered another quarter of strong profits and record engagement,” said Jeff Tangney, co-founder and CEO of Doximity ( DOCS ). “We’re proud to bring AI and automation to clinical workflows, with over 580,000 unique providers using our workflow tools last quarter.”

Doximity ( DOCS ) highlighted that its board authorized a repurchase program of up to $500 million of the company’s common stock on May 1. The company noted that all prior repurchase programs were completed as of April 2024.

Outlook: Doximity ( DOCS ) expects first-quarter revenue to be between $119.5 million and $120.5 million versus estimates of $119.23 million. Full-year revenue is expected to be between $506 million and $518 million versus estimates of $520.772 million, according to Benzinga Pro.

Doximity ( DOCS ) also guided for first-quarter adjusted EBITDA of $55 million to $65 million and full-year adjusted EBITDA of $238 million to $250 million.

A conference call with more details on the company’s quarter is scheduled for 5 p.m. ET.

DOCS Price Action: Doximity ( DOCS ) shares were up 11.54% after hours at $26.48 at the time of publication, according to Benzinga Pro.

Check This Out: David Tepper Bullish On China: Alibaba Now No. 1 Holding, Trimmed Stakes In Nvidia, Microsoft, Amazon, Meta, Google